Squarepoint’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-446,018
| Closed | -$18.2M | – | 3162 |
|
|
2024
Q2 | $18.2M | Buy |
446,018
+354,333
| +386% | +$14.5M | 0.03% | 318 |
|
|
2024
Q1 | $3.88M | Buy |
91,685
+9,494
| +12% | +$401K | 0.01% | 797 |
|
|
2023
Q4 | $3.48M | Buy |
82,191
+57,327
| +231% | +$2.43M | 0.01% | 799 |
|
|
2023
Q3 | $543K | Buy |
+24,864
| New | +$543K | ﹤0.01% | 1594 |
|
|
2023
Q2 | – | Sell |
-32,300
| Closed | -$788K | – | 2948 |
|
|
2023
Q1 | $788K | Sell |
32,300
-21,504
| -40% | -$524K | ﹤0.01% | 1275 |
|
|
2022
Q4 | $1.7M | Sell |
53,804
-18,740
| -26% | -$591K | 0.01% | 849 |
|
|
2022
Q3 | $2.05M | Buy |
+72,544
| New | +$2.05M | 0.01% | 773 |
|
|
2022
Q2 | – | Sell |
-9,403
| Closed | -$329K | – | 2761 |
|
|
2022
Q1 | $329K | Buy |
9,403
+264
| +3% | +$9.24K | ﹤0.01% | 1688 |
|
|
2021
Q4 | $296K | Sell |
9,139
-66,248
| -88% | -$2.15M | ﹤0.01% | 1875 |
|
|
2021
Q3 | $2.22M | Buy |
+75,387
| New | +$2.22M | 0.01% | 746 |
|